中国医师协会“星火计划“暨国家消化系统肿瘤MDT试点项目工作会在京召开

2019-01-18 向玉 MDT专委会

会议现场2019年1月14日,中国医师协会“星火计划“暨国家消化系统肿瘤MDT试点项目工作会在北京新疆大厦圆满召开!国家卫生健康委医政医管局焦雅辉副局长、中国医师协会石丽英副秘书长、国家卫生健康委医政医管局医疗资源处王斐主任、中国医师协会学术会务部华立副主任、中国医师协会外科医师分会王杉会长、外科分会总干事姜可伟教授、中国医师协会外科医师分会MDT专委会主任委员沈琳教授和叶颖江教授出席会议,同

会议现场

2019年1月14日,中国医师协会“星火计划“暨国家消化系统肿瘤MDT试点项目工作会在北京新疆大厦圆满召开!国家卫生健康委医政医管局焦雅辉副局长、中国医师协会石丽英副秘书长、国家卫生健康委医政医管局医疗资源处王斐主任、中国医师协会学术会务部华立副主任、中国医师协会外科医师分会王杉会长、外科分会总干事姜可伟教授、中国医师协会外科医师分会MDT专委会主任委员沈琳教授和叶颖江教授出席会议,同时全国参与本次试点工作的200多家医院的代表、共计300余人参加了本次会议。



领导及嘉宾合影

————————————————————————————————————————————

参会领导:

焦雅辉  国家卫健委医政医管局副局长

石丽英  中国医师协会副秘书长

王    斐  卫健委医政医管局医疗资源处主任

华    立  中国医师协会学术会务部秘书长

———————————————————————————————————————

参会领导:

王    杉  中国医师协会外科医师分会会长

姜可伟  中国医师协会外科医师分会总干事

沈    琳  中国医师协会外科分会MDT专委会主任委员

叶颖江  中国医师协会外科分会MDT专委会主任委员

国家卫健委医政医管局副局长焦雅辉指出:本次MDT诊疗全国试点项目已经被列为国家试点工作项目,在2019年刚刚结束的全国医疗管理工作会上专门强调了MDT诊疗模式的重要性。MDT诊疗模式不仅仅是一个诊疗模式,也是推进学术交流的一个重要环节,在全国推广的过程中,需要政策上的支持,而政策往往是滞后于实践的,一个政策的实现,需要由实践的探索和经验总结,然后形成一项制度,最后再上升为国家的政策,这是必然的路径。在国家卫健委2018年下发的《关于印发进一步改善医疗服务行动计划(2018-2020年)的通知》中,首先提出要把MDT诊疗模式作为医院诊疗的常规制度,这是为了将MDT诊疗模式固定下来。此次我们从国家政策层面进行推进,是MDT诊疗模式最好的机遇和发展的时机。

肿瘤作为威胁国人健康最主要的疾病之一,国家对提高国内肿瘤诊治水平高度重视,国务院李克强总理在2018年做报告的时候提出要“攻克肿瘤防治的难关”;即将到来的国务院常务会,总理将会听取国家卫健委、药监局对于肿瘤防治相关工作情况的汇报。其次,最近有17种抗癌药加入了医保,这也是国家前所未有的政策上支持。近些年,我国肿瘤的防治取得了明显的成效,早诊早治率有很大的提高,然而目前我们的整体诊治效果与发达国家还是有比较大的差距,因此推行MDT诊疗模式对于提高我国肿瘤防治水平具有重要意义。我国目前的肿瘤现状,如肺癌、肝癌、癌的发病率和死亡率非常高的,所以此次选择消化系统这个比较有代表性的方向,在这个领域先推行,希望通过这个领域摸索出符合我国实际情况的一些规律。焦雅辉副局长同时指出,此次在国家政策推动下开展MDT试点工作,将会在中国未来的医学发展史上,留下浓墨重彩的一笔,参与到此次项目的试点医院应该感到骄傲,也希望参与的医院可以献计献策,更好地促进这个项目推动,取得真正的成效,为中国肿瘤防治事业的发展做出贡献。

中国医师协会石丽英副秘书长表示:中国医师协会作为全国医师之家,成立17年来,始终秉承“服务、协调、维权、自律、监督、管理”的宗旨,竭诚为医师服务、维护医师的权益,深得广大医师的支持和拥护。目前,全国已成立44个地方医师协会和85个专科医师分会/专业委员会。2015年外科医师分会成立MDT专委会,并在国内开展了一系列以“推广MDT理念、规范MDT组织实施”为主题的“百城行”活动,覆盖医院百余家,接受培训人员逾万人。为了能让肿瘤MDT诊疗模式更好的在落地执行,MDT专委会启动以落地MDT模式为目的《星火计划》项目,并承担了国家消化系统肿瘤MDT试点工作,意义重大,对提高全国各级医院肿瘤专业化水平和提高医疗服务具有重要作用,MDT专委会作为中国医师协会的分支机构能够承担该项目的具体实施工作,也是体现了政府和社会对专委会既往工作的认可。中国医师协会将在国家卫健委医政医管局的指导下,做好试点工作。进一步完善MDT规范诊疗流程,对项目的落实和试点医院的评估做好监督、管理工作,保证该项目的顺利实施。

中国医师协会外科医师分会王杉会长表示:MDT诊疗模式,目前已是国际指南中规定的诊疗模式,在英国,MDT已被列入法律条款。所以,MDT不仅仅是一种模式,还是一种理念的体现。过去10年经过包括王杉教授、沈琳教授、叶颖江教授等一批致力于MDT事业的医生和MDT专委会等相关协会的探索和实践,为MDT理念的推广打下了基础,目前MDT模式获得国家层面的重视,并给予了政策支持,大力推进,这是一个具有里程碑意义的时刻。期待随着试点工作的开展,未来我们国家也能有与MDT相配套的条款、医保政策等出台,为MDT的普及提供更多的支持,让广大的患者、百姓受益。

MDT专委会主任委员沈琳教授指出:消化肿瘤MDT试点工作是由国家卫健委医政医管局和中国医师协会共同发起,为的是探索MDT诊疗模式如何在我国更好地实现和执行,以及配合完善我国MDT诊疗模式的管理体系、推动政策和原则的制定。MDT诊疗模式,不仅可以扩大患者的受益,还可以有效推动各学科的学术交流,也是我国目前医改政策中一个很重要的项目,此次参与试点的医院共计300余家。希望在未来几年,MDT专委会可以推动这项工作落实到每一个试点中心。同时也期盼在国家卫健委的领导下、中国医师协会的支持下,在不远的将来,让我国肿瘤的诊疗水平上升一个台阶。

北京大学人民医院申占龙教授(MDT专委会副秘书长),就MDT的发展历史、国内开展情况、MDT的优势以及MDT如何实施做了《MDT诊疗模式在国内的探索和推广》的专题报告。

国家卫健委医政医管局医疗资源处王斐主任做了主题为《进一步改善医疗服务 增强人民群众获得感》的专题报告,从政府角度,就此次全国消化系统肿瘤MDT试点工作开展具体情况进行了详细介绍,他指出以习近平总书记为核心的党和国家领导人对于医疗服务高度重视,国家卫健委为贯彻落实总书记的重要指示精神,将改革重点聚焦在四个方面:解决看病“三长一短”问题、解决疑难复杂疾病的规范化诊治问题、解决“住院手术难”问题、解决急危重症救治问题。为实现该目标,国家卫健委启动2018-2020年改善医疗服务行动计划,主要内容包括建立健全5项工作制度,形成长效工作机制;创新10项医疗服务模式,满足医疗服务新需求,并对5项制度和10项模式进行了详细的阐述。肿瘤多学科诊疗试点工作是创新医疗模式的重要举措,在印发《关于开展肿瘤多学科试点工作的通知》中已明确:“2018-2020年,在全国范围内开展肿瘤多学科诊疗试点工作,率先在具有肿瘤诊疗相关临床专科的三级综合医院和肿瘤专科医院,首先选择消化系统开展。”在印发《第一批肿瘤(消化系统)多学科诊疗试点医院名单的通知》中明确了:“遴选了231家医院作为第一批肿瘤(消化系统)多学科诊疗试点医院。”并对231家试点医院提出了未来工作的寄望。

北京大学肿瘤医院陆明教授(MDT专委会秘书长)从协会角度介绍了中国医师协会MDT专委会的MDT工作开展情况,MDT推广工作的三阶段工作计划,理念推广阶段→MDT模式落地阶段→MDT模式推广阶段,第一阶段开展的“百城行”活动达到了推广MDT理念,做到了让医院了解MDT、专委会了解国内医院MDT开展情况的目的;“星火计划”是第二阶段,目的是配合国家政策,落实MDT诊疗模式落地,改善医疗服务,探索MDT可推广的模式,参与到本项目的医院除了首批卫健委试点医院之外,还有主动报名参加的医院,总数超过300家,后续专委会将以这些医院为中心,在国家卫健委指导下,在中国医师协会、中国医师协会外科医师分会的支持下,开展多个系列活动,建立统一的数据库和互联网平台,并配合卫健委进行试点医院评估,以达到最终试点的目的。

随后作为“百城行”活动中的MDT开展的典范,九江市第一人民医院熊功友院长做了《“生命活水”的MDT之路》的主题报告,他详细地介绍了九江市第一人民·生命活水医院在开展MDT工作中的思路、实践过程、经验分享、取得的成绩等。为参与到此次试点工作中的医院提供了参考。

博鳌医学创新研究院刘洪教授介绍了肿瘤MDT试点工作考核步骤、MDT诊疗流程、MDT门诊流程,然后阐述了考核方案的制定依据、参考的指南和标准。详细说明了MDT试点医院考核的标准、评测方法、日程安排、报告提交、参考模板等,并且从专业角度给予“建立高质量MDT”的建议。

索闻博识科技(北京)有限公司邵涛博士和医渡云(北京)技术有限公司安超博士就数据库的建设情况进行了说明。

北京和缓医疗科技有限公司联合创始人倪县乐博士介绍了MDT远程平台的搭建情况和活动计划。

大会最后,沈琳教授对会议进行了总结,再次强调了此次试点工作的重要意义,并对所有试点医院提出了期许。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1663150, encodeId=318716631508e, content=<a href='/topic/show?id=fff221e29fd' target=_blank style='color:#2F92EE;'>#中国医师协会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21729, encryptionId=fff221e29fd, topicName=中国医师协会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9ce25527825, createdName=ms6897892027066920, createdTime=Thu Jun 27 03:47:00 CST 2019, time=2019-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1925038, encodeId=fd76192503823, content=<a href='/topic/show?id=732b65e60b0' target=_blank style='color:#2F92EE;'>#消化系统肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65760, encryptionId=732b65e60b0, topicName=消化系统肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Wed Mar 06 23:47:00 CST 2019, time=2019-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977327, encodeId=8c0a19e732700, content=<a href='/topic/show?id=d7e321e287d' target=_blank style='color:#2F92EE;'>#中国医师#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21728, encryptionId=d7e321e287d, topicName=中国医师)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Fri Dec 20 11:47:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1985942, encodeId=599e1985942cd, content=<a href='/topic/show?id=7d41596895d' target=_blank style='color:#2F92EE;'>#星火计划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59689, encryptionId=7d41596895d, topicName=星火计划)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sat Mar 23 08:47:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641681, encodeId=177b16416819b, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Thu Feb 21 09:47:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462669, encodeId=335f146266998, content=<a href='/topic/show?id=bfec65e55e8' target=_blank style='color:#2F92EE;'>#消化系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65755, encryptionId=bfec65e55e8, topicName=消化系统)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00a96514473, createdName=jambiya, createdTime=Sun Jan 20 13:47:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490771, encodeId=a2f71490e718d, content=<a href='/topic/show?id=7ad31142900' target=_blank style='color:#2F92EE;'>#MDT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11429, encryptionId=7ad31142900, topicName=MDT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5e8811447, createdName=jiangfeng5070, createdTime=Sun Jan 20 13:47:00 CST 2019, time=2019-01-20, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1663150, encodeId=318716631508e, content=<a href='/topic/show?id=fff221e29fd' target=_blank style='color:#2F92EE;'>#中国医师协会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21729, encryptionId=fff221e29fd, topicName=中国医师协会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9ce25527825, createdName=ms6897892027066920, createdTime=Thu Jun 27 03:47:00 CST 2019, time=2019-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1925038, encodeId=fd76192503823, content=<a href='/topic/show?id=732b65e60b0' target=_blank style='color:#2F92EE;'>#消化系统肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65760, encryptionId=732b65e60b0, topicName=消化系统肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Wed Mar 06 23:47:00 CST 2019, time=2019-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977327, encodeId=8c0a19e732700, content=<a href='/topic/show?id=d7e321e287d' target=_blank style='color:#2F92EE;'>#中国医师#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21728, encryptionId=d7e321e287d, topicName=中国医师)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Fri Dec 20 11:47:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1985942, encodeId=599e1985942cd, content=<a href='/topic/show?id=7d41596895d' target=_blank style='color:#2F92EE;'>#星火计划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59689, encryptionId=7d41596895d, topicName=星火计划)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sat Mar 23 08:47:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641681, encodeId=177b16416819b, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Thu Feb 21 09:47:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462669, encodeId=335f146266998, content=<a href='/topic/show?id=bfec65e55e8' target=_blank style='color:#2F92EE;'>#消化系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65755, encryptionId=bfec65e55e8, topicName=消化系统)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00a96514473, createdName=jambiya, createdTime=Sun Jan 20 13:47:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490771, encodeId=a2f71490e718d, content=<a href='/topic/show?id=7ad31142900' target=_blank style='color:#2F92EE;'>#MDT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11429, encryptionId=7ad31142900, topicName=MDT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5e8811447, createdName=jiangfeng5070, createdTime=Sun Jan 20 13:47:00 CST 2019, time=2019-01-20, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1663150, encodeId=318716631508e, content=<a href='/topic/show?id=fff221e29fd' target=_blank style='color:#2F92EE;'>#中国医师协会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21729, encryptionId=fff221e29fd, topicName=中国医师协会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9ce25527825, createdName=ms6897892027066920, createdTime=Thu Jun 27 03:47:00 CST 2019, time=2019-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1925038, encodeId=fd76192503823, content=<a href='/topic/show?id=732b65e60b0' target=_blank style='color:#2F92EE;'>#消化系统肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65760, encryptionId=732b65e60b0, topicName=消化系统肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Wed Mar 06 23:47:00 CST 2019, time=2019-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977327, encodeId=8c0a19e732700, content=<a href='/topic/show?id=d7e321e287d' target=_blank style='color:#2F92EE;'>#中国医师#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21728, encryptionId=d7e321e287d, topicName=中国医师)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Fri Dec 20 11:47:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1985942, encodeId=599e1985942cd, content=<a href='/topic/show?id=7d41596895d' target=_blank style='color:#2F92EE;'>#星火计划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59689, encryptionId=7d41596895d, topicName=星火计划)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sat Mar 23 08:47:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641681, encodeId=177b16416819b, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Thu Feb 21 09:47:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462669, encodeId=335f146266998, content=<a href='/topic/show?id=bfec65e55e8' target=_blank style='color:#2F92EE;'>#消化系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65755, encryptionId=bfec65e55e8, topicName=消化系统)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00a96514473, createdName=jambiya, createdTime=Sun Jan 20 13:47:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490771, encodeId=a2f71490e718d, content=<a href='/topic/show?id=7ad31142900' target=_blank style='color:#2F92EE;'>#MDT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11429, encryptionId=7ad31142900, topicName=MDT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5e8811447, createdName=jiangfeng5070, createdTime=Sun Jan 20 13:47:00 CST 2019, time=2019-01-20, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1663150, encodeId=318716631508e, content=<a href='/topic/show?id=fff221e29fd' target=_blank style='color:#2F92EE;'>#中国医师协会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21729, encryptionId=fff221e29fd, topicName=中国医师协会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9ce25527825, createdName=ms6897892027066920, createdTime=Thu Jun 27 03:47:00 CST 2019, time=2019-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1925038, encodeId=fd76192503823, content=<a href='/topic/show?id=732b65e60b0' target=_blank style='color:#2F92EE;'>#消化系统肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65760, encryptionId=732b65e60b0, topicName=消化系统肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Wed Mar 06 23:47:00 CST 2019, time=2019-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977327, encodeId=8c0a19e732700, content=<a href='/topic/show?id=d7e321e287d' target=_blank style='color:#2F92EE;'>#中国医师#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21728, encryptionId=d7e321e287d, topicName=中国医师)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Fri Dec 20 11:47:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1985942, encodeId=599e1985942cd, content=<a href='/topic/show?id=7d41596895d' target=_blank style='color:#2F92EE;'>#星火计划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59689, encryptionId=7d41596895d, topicName=星火计划)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sat Mar 23 08:47:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641681, encodeId=177b16416819b, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Thu Feb 21 09:47:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462669, encodeId=335f146266998, content=<a href='/topic/show?id=bfec65e55e8' target=_blank style='color:#2F92EE;'>#消化系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65755, encryptionId=bfec65e55e8, topicName=消化系统)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00a96514473, createdName=jambiya, createdTime=Sun Jan 20 13:47:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490771, encodeId=a2f71490e718d, content=<a href='/topic/show?id=7ad31142900' target=_blank style='color:#2F92EE;'>#MDT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11429, encryptionId=7ad31142900, topicName=MDT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5e8811447, createdName=jiangfeng5070, createdTime=Sun Jan 20 13:47:00 CST 2019, time=2019-01-20, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1663150, encodeId=318716631508e, content=<a href='/topic/show?id=fff221e29fd' target=_blank style='color:#2F92EE;'>#中国医师协会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21729, encryptionId=fff221e29fd, topicName=中国医师协会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9ce25527825, createdName=ms6897892027066920, createdTime=Thu Jun 27 03:47:00 CST 2019, time=2019-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1925038, encodeId=fd76192503823, content=<a href='/topic/show?id=732b65e60b0' target=_blank style='color:#2F92EE;'>#消化系统肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65760, encryptionId=732b65e60b0, topicName=消化系统肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Wed Mar 06 23:47:00 CST 2019, time=2019-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977327, encodeId=8c0a19e732700, content=<a href='/topic/show?id=d7e321e287d' target=_blank style='color:#2F92EE;'>#中国医师#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21728, encryptionId=d7e321e287d, topicName=中国医师)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Fri Dec 20 11:47:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1985942, encodeId=599e1985942cd, content=<a href='/topic/show?id=7d41596895d' target=_blank style='color:#2F92EE;'>#星火计划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59689, encryptionId=7d41596895d, topicName=星火计划)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sat Mar 23 08:47:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641681, encodeId=177b16416819b, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Thu Feb 21 09:47:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462669, encodeId=335f146266998, content=<a href='/topic/show?id=bfec65e55e8' target=_blank style='color:#2F92EE;'>#消化系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65755, encryptionId=bfec65e55e8, topicName=消化系统)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00a96514473, createdName=jambiya, createdTime=Sun Jan 20 13:47:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490771, encodeId=a2f71490e718d, content=<a href='/topic/show?id=7ad31142900' target=_blank style='color:#2F92EE;'>#MDT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11429, encryptionId=7ad31142900, topicName=MDT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5e8811447, createdName=jiangfeng5070, createdTime=Sun Jan 20 13:47:00 CST 2019, time=2019-01-20, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1663150, encodeId=318716631508e, content=<a href='/topic/show?id=fff221e29fd' target=_blank style='color:#2F92EE;'>#中国医师协会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21729, encryptionId=fff221e29fd, topicName=中国医师协会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9ce25527825, createdName=ms6897892027066920, createdTime=Thu Jun 27 03:47:00 CST 2019, time=2019-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1925038, encodeId=fd76192503823, content=<a href='/topic/show?id=732b65e60b0' target=_blank style='color:#2F92EE;'>#消化系统肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65760, encryptionId=732b65e60b0, topicName=消化系统肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Wed Mar 06 23:47:00 CST 2019, time=2019-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977327, encodeId=8c0a19e732700, content=<a href='/topic/show?id=d7e321e287d' target=_blank style='color:#2F92EE;'>#中国医师#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21728, encryptionId=d7e321e287d, topicName=中国医师)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Fri Dec 20 11:47:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1985942, encodeId=599e1985942cd, content=<a href='/topic/show?id=7d41596895d' target=_blank style='color:#2F92EE;'>#星火计划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59689, encryptionId=7d41596895d, topicName=星火计划)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sat Mar 23 08:47:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641681, encodeId=177b16416819b, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Thu Feb 21 09:47:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462669, encodeId=335f146266998, content=<a href='/topic/show?id=bfec65e55e8' target=_blank style='color:#2F92EE;'>#消化系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65755, encryptionId=bfec65e55e8, topicName=消化系统)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00a96514473, createdName=jambiya, createdTime=Sun Jan 20 13:47:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490771, encodeId=a2f71490e718d, content=<a href='/topic/show?id=7ad31142900' target=_blank style='color:#2F92EE;'>#MDT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11429, encryptionId=7ad31142900, topicName=MDT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5e8811447, createdName=jiangfeng5070, createdTime=Sun Jan 20 13:47:00 CST 2019, time=2019-01-20, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1663150, encodeId=318716631508e, content=<a href='/topic/show?id=fff221e29fd' target=_blank style='color:#2F92EE;'>#中国医师协会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21729, encryptionId=fff221e29fd, topicName=中国医师协会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9ce25527825, createdName=ms6897892027066920, createdTime=Thu Jun 27 03:47:00 CST 2019, time=2019-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1925038, encodeId=fd76192503823, content=<a href='/topic/show?id=732b65e60b0' target=_blank style='color:#2F92EE;'>#消化系统肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65760, encryptionId=732b65e60b0, topicName=消化系统肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Wed Mar 06 23:47:00 CST 2019, time=2019-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977327, encodeId=8c0a19e732700, content=<a href='/topic/show?id=d7e321e287d' target=_blank style='color:#2F92EE;'>#中国医师#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21728, encryptionId=d7e321e287d, topicName=中国医师)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Fri Dec 20 11:47:00 CST 2019, time=2019-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1985942, encodeId=599e1985942cd, content=<a href='/topic/show?id=7d41596895d' target=_blank style='color:#2F92EE;'>#星火计划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59689, encryptionId=7d41596895d, topicName=星火计划)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sat Mar 23 08:47:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641681, encodeId=177b16416819b, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Thu Feb 21 09:47:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1462669, encodeId=335f146266998, content=<a href='/topic/show?id=bfec65e55e8' target=_blank style='color:#2F92EE;'>#消化系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65755, encryptionId=bfec65e55e8, topicName=消化系统)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00a96514473, createdName=jambiya, createdTime=Sun Jan 20 13:47:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490771, encodeId=a2f71490e718d, content=<a href='/topic/show?id=7ad31142900' target=_blank style='color:#2F92EE;'>#MDT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11429, encryptionId=7ad31142900, topicName=MDT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5e8811447, createdName=jiangfeng5070, createdTime=Sun Jan 20 13:47:00 CST 2019, time=2019-01-20, status=1, ipAttribution=)]
    2019-01-20 jiangfeng5070

相关资讯

“星火计划-头颈肿瘤MDT中心交流访问项目”近期在上海启动

由中国抗癌协会头颈肿瘤专业委员会发起的“星火计划-头颈肿瘤MDT中心(MDT是Multi-Disciplinary Treatment的缩写,即头颈肿瘤综合治疗多学科协作)交流访问项目”在上海启动,该项目旨在通过国内医院之间的交流和互访,分享各医院在头颈肿瘤MDT方面的经验,提升国内头颈肿瘤综合诊治的水平,从而给患者带来更大的生存获益。